128 related articles for article (PubMed ID: 2227729)
1. Evaluation of a commercial radioimmunoassay kit for the detection of lysergide (LSD) in serum, whole blood, urine and stomach contents.
Altunkaya D; Smith RN
Forensic Sci Int; 1990 Sep; 47(2):113-21. PubMed ID: 2227729
[TBL] [Abstract][Full Text] [Related]
2. The analysis of lysergide (LSD): the development of novel enzyme immunoassay and immunoaffinity extraction procedures together with an HPLC-MS confirmation procedure.
Webb KS; Baker PB; Cassells NP; Francis JM; Johnston DE; Lancaster SL; Minty PS; Reed GD; White SA
J Forensic Sci; 1996 Nov; 41(6):938-46. PubMed ID: 8914284
[TBL] [Abstract][Full Text] [Related]
3. The development and evaluation of a 125I radioimmunoassay for the measurement of LSD in body fluids.
Stead AH; Watton J; Goddard CP; Patel AC; Moffat AC
Forensic Sci Int; 1986; 32(1):49-60. PubMed ID: 3770601
[TBL] [Abstract][Full Text] [Related]
4. Comparison of EMIT II, CEDIA, and DPC RIA assays for the detection of lysergic acid diethylamide in forensic urine samples.
Wiegand RF; Klette KL; Stout PR; Gehlhausen JM
J Anal Toxicol; 2002 Oct; 26(7):519-23. PubMed ID: 12423010
[TBL] [Abstract][Full Text] [Related]
5. Immunochemical extraction and detection of LSD in whole blood.
Kerrigan S; Brooks DE
J Immunol Methods; 1999 Apr; 224(1-2):11-8. PubMed ID: 10357201
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunoassay of lysergic acid diethylamide (LSD) in serum and urine by using antisera of different specificities.
Ratcliffe WA; Fletcher SM; Moffat AC; Ratcliffe JG; Harland WA; Levitt TE
Clin Chem; 1977 Feb; 23(2 PT. 1):169-74. PubMed ID: 832379
[TBL] [Abstract][Full Text] [Related]
7. Automated extraction of lysergic acid diethylamide (LSD) and N-demethyl-LSD from blood, serum, plasma, and urine samples using the Zymark RapidTrace with LC/MS/MS confirmation.
de Kanel J; Vickery WE; Waldner B; Monahan RM; Diamond FX
J Forensic Sci; 1998 May; 43(3):622-5. PubMed ID: 9608700
[TBL] [Abstract][Full Text] [Related]
8. Body fluid levels of lysergide (LSD).
Smith RN; Robinson K
Forensic Sci Int; 1985 Aug; 28(3-4):229-37. PubMed ID: 4065782
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a nonisotopic immunoassay for the detection of LSD in human urine.
Cassells NP; Craston DH; Hand CW; Baldwin D
J Anal Toxicol; 1996 Oct; 20(6):409-15. PubMed ID: 8889677
[TBL] [Abstract][Full Text] [Related]
10. Liquid chromatography-electrospray ionization mass spectrometry for the detection of lysergide and a major metabolite, 2-oxo-3-hydroxy-LSD, in urine and blood.
Sklerov JH; Magluilo J; Shannon KK; Smith ML
J Anal Toxicol; 2000 Oct; 24(7):543-9. PubMed ID: 11043657
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a rapid turboflow LC-MS/MS method for the quantification of LSD and 2-oxo-3-hydroxy LSD in serum and urine samples of emergency toxicological cases.
Dolder PC; Liechti ME; Rentsch KM
Anal Bioanal Chem; 2015 Feb; 407(6):1577-84. PubMed ID: 25542574
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunoassay for lysergide (LSD) in illicit drugs and biological fluids.
Loeffler LJ; Pierce JV
J Pharm Sci; 1973 Nov; 62(11):1817-20. PubMed ID: 4758079
[No Abstract] [Full Text] [Related]
13. Analysis of LSD in human body fluids by high-performance liquid chromatography, fluorescence spectroscopy and radioimmunoassay.
Twitchett PJ; Fletcher SM; Sullivan AT; Moffat AC
J Chromatogr; 1978 Mar; 150(1):73-84. PubMed ID: 641124
[TBL] [Abstract][Full Text] [Related]
14. Gas chromatographic/mass spectrometric determination of lysergic acid diethylamide (LSD) in serum samples.
Musshoff F; Daldrup T
Forensic Sci Int; 1997 Aug; 88(2):133-40. PubMed ID: 9251232
[TBL] [Abstract][Full Text] [Related]
15. Confirmation of LSD intoxication by analysis of serum and urine.
McCarron MM; Walberg CB; Baselt RC
J Anal Toxicol; 1990; 14(3):165-7. PubMed ID: 2374406
[TBL] [Abstract][Full Text] [Related]
16. Quantitative determination of LSD and a major metabolite, 2-oxo-3-hydroxy-LSD, in human urine by solid-phase extraction and gas chromatography-tandem mass spectrometry.
Reuschel SA; Percey SE; Liu S; Eades DM; Foltz RL
J Anal Toxicol; 1999 Sep; 23(5):306-12. PubMed ID: 10488916
[TBL] [Abstract][Full Text] [Related]
17. Validation of an LC-MS/MS method for the quantitative analysis of 1P-LSD and its tentative metabolite LSD in fortified urine and serum samples including stability tests for 1P-LSD under different storage conditions.
Grumann C; Henkel K; Stratford A; Hermanns-Clausen M; Passie T; Brandt SD; Auwärter V
J Pharm Biomed Anal; 2019 Sep; 174():270-276. PubMed ID: 31181490
[TBL] [Abstract][Full Text] [Related]
18. Immunoassay analysis of lysergic acid diethylamide.
Cody JT; Valtier S
J Anal Toxicol; 1997 Oct; 21(6):459-64. PubMed ID: 9323526
[TBL] [Abstract][Full Text] [Related]
19. [Detection of lysergic acid diethylamide in human urine: elimination, screening and analytical confirmation].
Vu-Duc T; Vernay A; Calanca A
Schweiz Med Wochenschr; 1991 Dec; 121(50):1887-90. PubMed ID: 1759150
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of an LC-MS/MS method to quantify lysergic acid diethylamide (LSD), iso-LSD, 2-oxo-3-hydroxy-LSD, and nor-LSD and identify novel metabolites in plasma samples in a controlled clinical trial.
Dolder PC; Liechti ME; Rentsch KM
J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28548305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
